Other ERBB-family-receptors (ERBB2, ERBB3, and ERBB4) were barely expressed in basal cancers, whereas non-basal BLCA showed increased mRNA expression of different ERBBs. Here, ERBB4 is linked to bladder transitional cell carcinoma.